Amgen Inc.

Pharmaceuticals

Company Summary

Amgen Inc. is a biotechnology company that develops, manufactures, and distributes human pharmaceuticals all over the world. Inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience are some of the topics covered. Amgen Inc. is based in Thousand Oaks, California, and was formed in 1980.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

19
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
0100E0S13.1G6.3

Refinitiv

Overall ESG Rating :

75
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E76S82G63

Overall ESG Rating :

AA
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

Amgen is a leader among 41 companies in the biotechnology industry.

Temperature Rise :

1.59℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned